Author of the publication

Metaplastic carcinoma of breast with heterologous mesenchymal differentiation (carcinosarcoma) having an endothelial component: a case report

, , , , , , , , , , and . Journal of Medical Case Reports, 19 (1): 470-- (December 2025)Case Report | First Published on 29 September 2025.
DOI: 10.1186/s13256-025-05574-8

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Bladder adjuvant radiation therapy (BART): acute and late toxicity from a phase III multicenter randomized controlled trial, , , , , , , , , and 11 other author(s). International Journal of Radiation Oncology*Biology*Physics, 121 (3): 728--736 (01 03 2025, © 2024)Clinical Investigation | First Published on 19 September 2024.Pregnancy-associated breast cancer, and . Springer, (01 2025, © 2024)Book Chapter | First Published on 16 January 2025.Metaplastic carcinoma of breast with heterologous mesenchymal differentiation (carcinosarcoma) having an endothelial component: a case report, , , , , , , , , and 1 other author(s). Journal of Medical Case Reports, 19 (1): 470-- (December 2025)Case Report | First Published on 29 September 2025.A phase III randomized clinical trial evaluating perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB), , , , , , , , , and 10 other author(s). Journal of Clinical Oncology, 43 (suppl.16): 4007 (May 2025)Abstract | First Published on 28 May 2025.Bladder adjuvant radiotherapy (BART): clinical outcomes from a phase III multicenter randomized controlled trial, , , , , , , , , and 10 other author(s). International Journal of Radiation Oncology, Biology, Physics, 123 (Suppl.1): S32-- (September 2025)Oral Scientific Abstracts | 1 September 2025.Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients, , , , , , , , , and 11 other author(s). Scientific Reports, 15 (1): 8 (May 2025)Scientific Reports | First Published on 28 May 2025.Custom made brachytherapy applicator for squamous cell carcinoma of oral commissures, , , , , and . Journal of Cancer Research and Therapeutics, 20 (5): 1632-1635 (July 2024)Case Report | First Published on 19 September 2024.The impact of radiation therapy and chemotherapy in locally advanced unresectable nonmetastatic pancreatic cancer patients treated in a tertiary care center, , , , , , , , , and . Journal of Cancer Research and Therapeutics, 21 (5): 1000--1005 (July 2025)Original Article | First Published on 26 September 2025.